Plain-English translation of NCT06917742 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial testing a new medication called that is given through an IV (intravenous) line. The study will involve healthy volunteers as well as people with moderate to severe rheumatoid arthritis or lupus to understand how safe the medication is and how the body processes it. Researchers will carefully watch for side effects and measure how well the treatment works.
This medication is completely new to human testing, so researchers need to first confirm that it is safe and well-tolerated before testing it more broadly. Understanding how the body responds to different doses will help determine if this treatment might help people with inflammatory conditions like arthritis and lupus.
You likely qualify if…
You likely don't qualify if…
Participants will receive the medication through an IV injection at scheduled study visits. The study has different groups: some healthy volunteers will receive one dose, others will receive multiple doses over time, and similar groups will include people with arthritis or lupus. You will have blood tests, physical exams, and monitoring at each visit to track your response to the medication and watch for any side effects.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Australia